Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
Abstract Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much attention in recent years. However, the...
Saved in:
| Main Authors: | Xinjia Du, Perkash Kumar, Chen Liu, Jiahua Liu, Lei Chen, Yuan Lu, Zhuoqi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04667-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
by: Xinjia Du, et al.
Published: (2024-11-01) -
Association between soluble suppression of tumorigenicity 2 and risk and severity of coronary artery disease: a case control study
by: Shuai Zhang, et al.
Published: (2025-04-01) -
Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis
by: Flavio Davini, et al.
Published: (2025-04-01) -
Prognostic value of serum HDAC2 and sST2 in occupational asthma patients
by: Ruifeng FENG, et al.
Published: (2024-11-01) -
Predictive value of lymphocyte-to-C-reactive protein ratio for left ventricular thrombus in patients with ST-segment elevation myocardial infarction
by: Xinjia Du, et al.
Published: (2025-04-01)